Jubilant Pharmova Q4FY23; Reported Losses

By Karan_Singh | May 31, 2023 7:41 am

Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101 crores in Q4FY23.

Tags: Radiopharma